Sep 16, 2013 | Health Tips, Research, Your Health
Ovarian cancer is a heterogeneous and rapidly progressive disease of low prevalence and poor survival. In the United States the number of deaths attributed to ovarian cancer approximates that of all other gynecologic malignancies combined. Unfortunately, the majority (75%) of women diagnosed with ovarian carcinoma continue to have advanced stage disease (Stage III/ IV), with widespread metastases throughout the peritoneal cavity, lymph nodes, liver or lungs. Presently less than 20% of women with ovarian cancers are detected when the cancer is still confined to the ovary (Stage I).
(more…)
Sep 15, 2013 | Research, Your Health
Glioblastoma (GBM) is the most common and most aggressive brain tumor, known to be a highly invasive and rapidly spreading disease. Even with aggressive treatment such as surgery, radiation, and chemotherapy, they are almost always incurable.
The Mount Sinai Comprehensive Brain Tumor Program is pioneering the use of electrical tumor treating fields to be used with conventional therapy. The device, manufactured by Novocure, is called NovoTTF and it is FDA approved for recurrent GBM. It consists of a head cap that produces changes in electrical fields, which is worn continuously.
(more…)
Sep 6, 2013 | Your Health
My name is Bill Weinzimmer and I am an advanced prostate cancer survivor. When I was diagnosed 18 years ago, I was told I only had 18 months to live. Thanks to the amazing care I received from Dr. Simon J. Hall at The Mount Sinai Hospital, and the significant changes I made in my life, I am still alive and active 18 years later at 83-years-young. I hope my experiences and tips will provide inspiration to others diagnosed with cancer, as well as to their families.
(more…)
Sep 6, 2013 | Inside, Your Health
Rapid industrialization in Southeast Asia is producing widespread environmental pollution, creating unsafe workplaces, and raising grave concerns for public health.
To address these challenges, and strengthen the capacity of health professionals and policymakers in Southeast Asia, Mount Sinai physicians under the leadership of Philip J. Landrigan, MD, MSc, the Ethel H. Wise Professor of Community Medicine and Dean for Global Health at The Mount Sinai Medical Center, have established a formal collaboration with the Chulabhorn Research Institute (CRI) in Bangkok, Thailand. Under the auspices of CRI and the World Health Organization (WHO), the physicians are sharing their knowledge and expertise with health care workers in Southeast Asia. Mount Sinai is world renowned for its work in environmental and occupational medicine.
(more…)
Sep 3, 2013 | Research, School, Your Health
Today’s standard therapies for cancer exist because people have participated in clinical trials – yet choosing to participate in a cancer clinical trial is an important personal decision that can be intimidating for many patients. In order to better help patients understand cancer clinical trials, the reasons to participate in them, and clinical research at Mount Sinai, The Tisch Cancer Institute has released a new video, “Clinical Trials at Mount Sinai: Moving the Field Forward.”
(more…)
Updated on Jun 30, 2022 | Your Health
As an orthopaedic surgeon for the Mount Sinai Medical Center, and appointed as the Chief Medical Officer for the USTA and the Medical Advisor to the U.S. Fed Cup team, I am honored to be a part of this venture as Mount Sinai is named the first-ever official medical service provider and hospital of the USTA and the US Open.
My colleague and orthopaedic surgeon, Dr. James Gladstone, will also serve as part of the medical team for the U.S. Open and the medical advisor to the U.S. Davis Cup team.
This five year partnership allows for continuity of care of the players during the U.S. Open. The current player medical services team already has had in place several Mount Sinai faculty, including Dr. Michael Yorio, the medical director.
(more…)
